{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:25:22Z","timestamp":1772558722457,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2012.03.056","type":"journal-article","created":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T14:01:25Z","timestamp":1333288885000},"page":"3369-3375","source":"Crossref","is-referenced-by-count":12,"title":["Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?"],"prefix":"10.1016","volume":"30","author":[{"given":"Marloes","family":"Bults","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desir\u00e9e J.M.A.","family":"Beaujean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clementine J.","family":"Wijkmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aura","family":"Timen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Hendrik","family":"Richardus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne A.C.M.","family":"Voeten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.03.056_bib0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(06)68266-4","article-title":"Q fever","volume":"367","author":"Parker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1473-3099(05)70052-9","article-title":"Natural history and pathophysiology of Q fever","volume":"5","author":"Raoult","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0015","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/CMR.12.4.518","article-title":"Q fever","volume":"12","author":"Maurin","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/321889","article-title":"Risks factors and prevention of Q fever endocarditis","volume":"33","author":"Fenollar","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/clinids\/20.3.489","article-title":"Q fever","volume":"20","author":"Raoult","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(92)90173-9","article-title":"Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases","volume":"93","author":"Tissot Dupont","year":"1992","journal-title":"Am J Med"},{"issue":"32","key":"10.1016\/j.vaccine.2012.03.056_bib0035","first-page":"pii=3247","article-title":"Q fever outbreak in the Netherlands: a preliminary report","volume":"12","author":"Karagiannis","year":"2007","journal-title":"Eurosurveill"},{"issue":"12","key":"10.1016\/j.vaccine.2012.03.056_bib0040","doi-asserted-by":"crossref","first-page":"pii=19520","DOI":"10.2807\/ese.15.12.19520-en","article-title":"Q fever in the Netherlands: an update on the epidemiology and control measures","volume":"15","author":"van der Hoek","year":"2010","journal-title":"Eurosurveill"},{"issue":"31","key":"10.1016\/j.vaccine.2012.03.056_bib0045","doi-asserted-by":"crossref","first-page":"pii=18939","DOI":"10.2807\/ese.13.31.18939-en","article-title":"Large ongoing Q fever outbreak in the south of the Netherlands, 2008","volume":"13","author":"Schimmer","year":"2008","journal-title":"Eurosurveill"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0050","unstructured":"Ministry of Health and Welfare. National Institute of Public Health and the Environment; 29 June 2011. Available from: http:\/\/www.rivm.nl\/Onderwerpen\/Ziekten_Aandoeningen\/Q\/Q_koorts."},{"key":"10.1016\/j.vaccine.2012.03.056_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2334-10-69","article-title":"The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak","volume":"10","author":"Schimmer","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0060","series-title":"Human Vaccination Against Q Fever","author":"Health Council of the Netherlands","year":"2010"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0065","unstructured":"CSL Biotherapies. Q-VAX Q fever vaccine and Q-VAX skin test. Product Information \u2013 TGA approved; 2008. Australia."},{"key":"10.1016\/j.vaccine.2012.03.056_bib0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5694\/j.1326-5377.1994.tb125909.x","article-title":"Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-VAX (CSL) 1985\u20131990","volume":"160","author":"Ackland","year":"1994","journal-title":"Med J Austr"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0075","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(84)91617-9","article-title":"Vaccine prophylaxis of abattoir-associated Q fever","volume":"2","author":"Marmion","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine prophylaxis of abattoir-associated Q fever: eight years\u2019 experience in Australian abattoirs","volume":"104","author":"Marmion","year":"1990","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0085","first-page":"400","article-title":"Q fever vaccine uptake in South Australian meat processors prior to the introduction of the national Q fever management program","volume":"29","author":"Milazzo","year":"2005","journal-title":"CDI"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.vaccine.2010.11.008","article-title":"Effectiveness of the Q fever vaccine: a meta-analysis","volume":"29","author":"Gefenaite","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/13698570802166431","article-title":"Communicating about emerging infectious disease: the importance of research","volume":"10","author":"Holmes","year":"2008","journal-title":"Health Risk Soc"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0100","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.2105\/AJPH.2009.162537","article-title":"Effective risk communication about pandemic influenza for vulnerable populations","volume":"99","author":"Vaughan","year":"2009","journal-title":"Am J Public Health"},{"issue":"14","key":"10.1016\/j.vaccine.2012.03.056_bib0105","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.vaccine.2009.02.007","article-title":"Australia's national Q fever vaccination program","volume":"27","author":"Gidding","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0110","doi-asserted-by":"crossref","DOI":"10.1002\/pd.2772","article-title":"Risks, trust and knowledge: determinants of pregnant women's decision regarding participation in a future Q fever screening and treatment program during a large epidemic in The Netherlands","author":"Breteler","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0115","unstructured":"Central Committee on Research involving Human Subjects. Manual for the review of medical research involving human subjects. Available from: www.ccmo-online.nl."},{"key":"10.1016\/j.vaccine.2012.03.056_bib0120","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1016\/j.vaccine.2011.06.075","article-title":"Pandemic influenza A (H1N1) vaccination in the Netherlands: parental reasoning underlying child vaccination choices","volume":"29","author":"Bults","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0125","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3201\/eid1008.040283","article-title":"SARS risk perception, knowledge, precautions, and information sources, the Netherlands","volume":"10","author":"Brug","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3201\/eid1302.060303","article-title":"Avian influenza risk perception, Europe and Asia","volume":"13","author":"de Zwart","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0135","series-title":"Predicting health behaviour","first-page":"81","article-title":"Protection motivation theory","author":"Norman","year":"2005"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0140","series-title":"Health Behaviour and Health Education; Theory, Research, and Practice","first-page":"45","article-title":"The health belief model","author":"Champion","year":"2008"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2003.09.020","article-title":"Physician and practice factors related to influenza vaccination among the elderly","volume":"26","author":"Zimmerman","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(00)00263-4","article-title":"Barriers to influenza immunization in a low-income urban population","volume":"20","author":"Armstrong","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2458-6-249","article-title":"Cross-sectional survey of older peoples\u2019 views related to influenza vaccine uptake","volume":"6","author":"Mangtani","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/ageing\/26.4.275","article-title":"Why do healthy elderly people fail to comply with influenza vaccination","volume":"26","author":"van Essen","year":"1997","journal-title":"Age Ageing"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0002-9343(91)90157-S","article-title":"Patient acceptance of influenza vaccination","volume":"91","author":"Fiebach","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9343(02)01421-3","article-title":"What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and veterans affairs practices","volume":"114","author":"Zimmerman","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0175","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1016\/j.vaccine.2004.12.031","article-title":"Factors influencing influenza vaccination uptake in an elderly, community-based sample","volume":"23","author":"Burns","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0180","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2105\/AJPH.93.12.2074","article-title":"Racial\/ethnic differences in influenza vaccination coverage in high-risk adults","volume":"93","author":"Egede","year":"2003","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2012.03.056_bib0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2807\/esm.08.06.00418-en","article-title":"Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake","volume":"8","author":"Kroneman","year":"2003","journal-title":"Eurosurveill"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T19:05:33Z","timestamp":1641927933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12004483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":37,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0264410X12004483"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}